Problems Associated with Co-Infection by Multidrug-Resistant in COVID-19 Patients: A Review

Overview

Journal Healthcare (Basel)

Specialty Health Services

Date 2022 Dec 23

PMID 36553936

Authors

Reham Omar Yahya

Affiliations

Soon will be listed here.

Abstract

To date, coronavirus disease 2019 (COVID-19) and its variants have been reported as a novel public health concern threatening us worldwide. The presence of in COVID-19-infected patients is a major problem due to its resistance to multiple antibiotics, and it can possibly make the management of COVID-19 in patients more problematic. The impact of co-infection by on COVID-19 patients was explored in the current review. The spread of as a co-infection among critically ill COVID-19 patients, particularly throughout hospitalization, was identified and recorded via numerous reports. Alarmingly, the extensive application of antibiotics in the initial diagnosis of COVID-19 infection may reduce bacterial co-infection, but it increases the antibiotic resistance of bacteria such as the strains of The correct detection of multidrug-resistant can offer a supportive reference for the diagnosis and therapeutic management of COVID-19 patients. Furthermore, the prevention and control of are required to minimize the risk of COVID-19. The aim of the present review is, therefore, to report on the virulence factors of the genotypes, the drug resistance of , and the impact of co-infection with COVID-19 on patients through a study of the published scientific papers, reports, and case studies.

Citing Articles

Is It Time to Start Worrying? A Comprehensive Report on the Three-Year Prevalence of ESBL-Producing Bacteria and Their Trends in Antibiotic Resistance from the Largest University Hospital in Slovakia.

Jalali Y, Kolosova A, Liptakova A, Kyselovic J, Olearova A, Jalali M Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598427 PMC: 11597623. DOI: 10.3390/ph17111517.

Infection with the multidrug-resistant Klebsiella pneumoniae New Delhi metallo-B-lactamase strain in patients with COVID-19: .

Janc J, Slabisz N, Wozniak A, Lysenko L, Chabowski M, Lesnik P Front Cell Infect Microbiol. 2024; 14:1297312.

PMID: 38690325 PMC: 11060079. DOI: 10.3389/fcimb.2024.1297312.

Polyproline peptide targets polysaccharides to collapse biofilms.

de Los Santos L, Beckman 4th R, DeBarro C, Keener J, Torres M, de la Fuente-Nunez C Cell Rep Phys Sci. 2024; 5(3).

PMID: 38605913 PMC: 11008256. DOI: 10.1016/j.xcrp.2024.101869.

Genomic, functional, and metabolic enhancements in multidrug-resistant Enterobacter bugandensis facilitating its persistence and succession in the International Space Station.

Sengupta P, Sivabalan S, Singh N, Raman K, Venkateswaran K Microbiome. 2024; 12(1):62.

PMID: 38521963 PMC: 10960378. DOI: 10.1186/s40168-024-01777-1.

The Dark Side of Nosocomial Infections in Critically Ill COVID-19 Patients.

Biondo C, Ponzo E, Midiri A, Ostone G, Mancuso G Life (Basel). 2023; 13(6).

PMID: 37374189 PMC: 10305261. DOI: 10.3390/life13061408.

References

Wang X, Xu X, Zhang S, Chen N, Sun Y, Ma K . TPGS-based and S-thanatin functionalized nanorods for overcoming drug resistance in Klebsiella pneumonia. Nat Commun. 2022; 13(1):3731. PMC: 9243133. DOI: 10.1038/s41467-022-31500-3. View

Hazra A, Collison M, Pisano J, Kumar M, Oehler C, Ridgway J . Coinfections with SARS-CoV-2 and other respiratory pathogens. Infect Control Hosp Epidemiol. 2020; 41(10):1228-1229. PMC: 7360954. DOI: 10.1017/ice.2020.322. View

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

Gorrie C, Mirceta M, Wick R, Edwards D, Thomson N, Strugnell R . Gastrointestinal Carriage Is a Major Reservoir of Klebsiella pneumoniae Infection in Intensive Care Patients. Clin Infect Dis. 2017; 65(2):208-215. PMC: 5850561. DOI: 10.1093/cid/cix270. View

Al-Zalabani A, AlThobyane O, Alshehri A, Alrehaili A, Namankani M, Aljafri O . Prevalence of Klebsiella pneumoniae Antibiotic Resistance in Medina, Saudi Arabia, 2014-2018. Cureus. 2020; 12(8):e9714. PMC: 7489314. DOI: 10.7759/cureus.9714. View

Tsereteli M, Sidamonidze K, Tsereteli D, Malania L, Vashakidze E . EPIDEMIOLOGY OF CARBAPENEM-RESISTANT KLEBSIELLA PNEUMONIAE IN INTENSIVE CARE UNITS OF MULTIPROFILE HOSPITALS IN TBILISI, GEORGIA. Georgian Med News. 2018; (280-281):164-168. View

Luo Y, Xie Y, Zhang W, Lin Q, Tang G, Wu S . Combination of lymphocyte number and function in evaluating host immunity. Aging (Albany NY). 2019; 11(24):12685-12707. PMC: 6949078. DOI: 10.18632/aging.102595. View

Azim N, Nofal M, Alharbi M, Al-Zaban M, Somily A . Molecular-diversity, Prevalence and Antibiotic Susceptibility of Pathogenic Klebsiella Pneumoniae under Saudi Condition. Pak J Biol Sci. 2020; 22(4):174-179. DOI: 10.3923/pjbs.2019.174.179. View

Santajit S, Indrawattana N . Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens. Biomed Res Int. 2016; 2016:2475067. PMC: 4871955. DOI: 10.1155/2016/2475067. View

10.

Santoso P, Sung M, Hartantri Y, Andriyoko B, Sugianli A, Alisjahbana B . MDR Pathogens Organisms as Risk Factor of Mortality in Secondary Pulmonary Bacterial Infections Among COVID-19 Patients: Observational Studies in Two Referral Hospitals in West Java, Indonesia. Int J Gen Med. 2022; 15:4741-4751. PMC: 9091686. DOI: 10.2147/IJGM.S359959. View

11.

Khan M, Mohamed A, Faiz A, Ahmad J . Enterobacterial infection in Saudi Arabia: First record of Klebsiella pneumoniae with triple carbapenemase genes resistance. J Infect Dev Ctries. 2020; 13(4):334-341. DOI: 10.3855/jidc.11056. View

12.

Garcia-Menino I, Forcelledo L, Rosete Y, Garcia-Prieto E, Escudero D, Fernandez J . Spread of OXA-48-producing Klebsiella pneumoniae among COVID-19-infected patients: The storm after the storm. J Infect Public Health. 2020; 14(1):50-52. PMC: 7713590. DOI: 10.1016/j.jiph.2020.11.001. View

13.

Farah S, Alshehri M, Alfawaz T, Alasmeri F, AlAgeel A, AlShahrani D . Trends in antimicrobial susceptibility patterns in King Fahad Medical City, Riyadh, Saudi Arabia. Saudi Med J. 2019; 40(3):252-259. PMC: 6468207. DOI: 10.15537/smj.2019.3.23947. View

14.

Chen W, Lai Y, Lin C, Zheng J, Hung W, Wang Y . First COVID-19 mortality case in Taiwan with bacterial co-infection by national surveillance of critically ill patients with influenza-negative pneumonia. J Microbiol Immunol Infect. 2020; 53(4):652-656. PMC: 7239019. DOI: 10.1016/j.jmii.2020.05.005. View

15.

Sakurai A, Sasaki T, Kato S, Hayashi M, Tsuzuki S, Ishihara T . Natural History of Asymptomatic SARS-CoV-2 Infection. N Engl J Med. 2020; 383(9):885-886. PMC: 7304419. DOI: 10.1056/NEJMc2013020. View

16.

Navon-Venezia S, Kondratyeva K, Carattoli A . Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev. 2017; 41(3):252-275. DOI: 10.1093/femsre/fux013. View

17.

Du X, He F, Shi Q, Zhao F, Xu J, Fu Y . The Rapid Emergence of Tigecycline Resistance in Harboring , as Mediated by Mutation in During Tigecycline Treatment. Front Microbiol. 2018; 9:648. PMC: 5895649. DOI: 10.3389/fmicb.2018.00648. View

18.

Mahmud Z, Uddin S, Moniruzzaman M, Ali S, Hossain M, Islam M . Healthcare Facilities as Potential Reservoirs of Antimicrobial Resistant : An Emerging Concern to Public Health in Bangladesh. Pharmaceuticals (Basel). 2022; 15(9). PMC: 9504507. DOI: 10.3390/ph15091116. View

19.

Brundage J, Shanks G . Deaths from bacterial pneumonia during 1918-19 influenza pandemic. Emerg Infect Dis. 2008; 14(8):1193-9. PMC: 2600384. DOI: 10.3201/eid1408.071313. View

20.

Galani I, Karaiskos I, Giamarellou H . Multidrug-resistant : mechanisms of resistance including updated data for novel β-lactam-β-lactamase inhibitor combinations. Expert Rev Anti Infect Ther. 2021; 19(11):1457-1468. DOI: 10.1080/14787210.2021.1924674. View